<DOC>
	<DOC>NCT01818544</DOC>
	<brief_summary>The primary objective of this study is to assess the safety and tolerability of 28 day oral administration of BAY85-8501 versus placebo in subjects with non-CF Bronchiectasis (BE). The secondary objectives are to examine the effect of BAY85-8501 on pulmonary function, biomarkers of inflammation and tissue damage, and the impact on overall health and perceived well-being and to evaluate the pharmacokinetics of BAY85-8501.</brief_summary>
	<brief_title>Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Proven and documented diagnosis of nonCF (cystic fibrosis) idiopathic or postinfectious BE (bronchiectasis) by computed tomography (CT) scan [conventional high resolution CT is considered the standard], including 2 or more lobes and dilated airways compatible with BE at initial diagnosis Stable pulmonary status as indicated by the forced, expired volume in 1 second (FEV1) percent predicted ≥30% and &lt;90% (postbronchodilator) Stable (i.e., no dose change) regimen of standard BE treatment administered at least for 4 weeks prior to screening Cough on most days Forced, expired volume in 1 second &lt;30% or ≥90% predicted (postbronchodilator) Recent significant hemoptysis (≥300 mL or requiring blood transfusion) in the preceding 4 weeks before screening (and during the screening period) Known cystic fibrosis and/or documented chronic bronchial asthma Active allergic bronchopulmonary aspergillosis (ABPA) Diagnosis of common variable immunodeficiency (CVID) Systemic or inhaled antibiotic treatment within 4 weeks prior to screening Treatment of an exacerbation within 4 weeks prior to screening Systemic corticosteroids at &gt;10 mg/day prednisolone equivalent for &gt;2 weeks within 4 weeks prior to screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Elastase Inhibition</keyword>
</DOC>